WeightWatchers soars after Sequence acquisition
4.8 (354) · € 25.50 · En Stock
WeightWatchers soared Tuesday after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
WeightWatchers to buy Sequence, enter weight loss drug market
WeightWatchers jumps into into the prescription weight loss drug
WW International Soars after Analyst Upgrade, Closes Sequence
WeightWatchers to Acquire Sequence, a Digital Health Platform for
WeightWatchers' stock soars after Sequence deal closes
Weight Watchers Reshapes Itself with a Game-Changer Acquisition
WW International's Ozempic Gamble (NASDAQ:WW)
Weight Watchers enters telehealth prescription drug space with
WeightWatchers seeks weight-loss drugs business in Sequence deal
WeightWatchers gets into prescription weight loss business
WeightWatchers (WW) Review: Does It Work in 2024?
Blake Madden en LinkedIn: #hospitals #healthcare
WeightWatchers moves into obesity drug market with Sequence
